Iron oxide injections to find melanoma sentinel lymph nodes
Part of Cancer, Skin clinical trials.
This trial tests whether a special injectable iron-based substance can help doctors better locate and remove sentinel lymph nodes (the first lymph nodes where melanoma might spread) during surgery. It compares this new method to standard approaches to see if it works just as well or better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have melanoma confirmed by a skin biopsy
- Your doctor has planned surgery to remove the melanoma and check your sentinel lymph nodes
- You are able to complete all study procedures and follow-up visits
- You are not pregnant or breastfeeding
- You do not have a history of iron overload disease (too much iron in your body)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a very small amount of a magnetic tracer called Magtrace can help find lymph nodes that need to be checked for cancer spread during breast cancer surgery.
This study tests a magnetic tracer call Magtrace to help find and remove the first lymph node (sentinel node) during breast cancer surgery. The goal is to see if it works well for people having breast-conserving surgery.
This trial tests a new treatment that combines a special iron injection (nano-carbon iron suspension) with standard radiation therapy for solid tumors. The goal is to see if the iron helps the radiation work better, possibly shrinking tumors more effectively.
This trial tests a new treatment for advanced solid tumors that uses tiny iron particles guided by carbon nanoparticles, injected directly into the tumor. It may be an option if standard treatments have stopped working or aren't available, and you have a tumor that can be safely injected.
This trial tests a new method using magnetic markers (Magtrace and Magseed) to find lymph nodes before chemotherapy. It may help doctors better target the lymph nodes that need to be removed during breast cancer surgery.
This trial tests whether contrast-enhanced ultrasound can help find sentinel lymph nodes (the first nodes cancer may spread to) in people with melanoma, breast, or head and neck cancer. It may reduce the need for a radioactive tracer injection.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.